Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-infected actin tails

Journal of General Virology

Volumn 85, Issue 5, 2004, Pages 1279-1290

  Law, Mansun ^a,b   Hollinshead, Michael ^a   Lee, Han Joo ^b,c   Smith, Geoffrey L ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTIBODY; CESIUM CHLORIDE; LIPID; MEMBRANE PROTEIN; REGULATOR PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; COMPLEMENT ACTIVATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ELECTRON MICROSCOPY; EXTRACELLULAR SPACE; GENETIC CODE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTRACELLULAR SPACE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN SYNTHESIS; TISSUE CULTURE; VACCINIA VIRUS; VIRION; VIROGENESIS; VIRUS ENVELOPE; VIRUS LOAD; VIRUS RECOMBINANT;

ACTINS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; COMPLEMENT SYSTEM PROTEINS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RECEPTORS, COMPLEMENT 3D; SEQUENCE ALIGNMENT; SOLUBILITY; VIRAL ENVELOPE PROTEINS; VIRION; YABA MONKEY TUMOR VIRUS;

PRIMATES; VACCINIA VIRUS; YABA-LIKE DISEASE VIRUS; YATAPOXVIRUS;

EID: 2442712536     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79863-0     Document Type: Article

References (40)

1. Adams, E. M., Brown, M. C., Nunge, M., Krych, M. & Atkinson, J. P. (1991). Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol 147, 3005-3011.
2. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F. & Rock, D. L. (2000). The genome of fowlpox virus. J Virol 74, 3815-3831.
3. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Osorio, F. A., Balinsky, C., Kutish, G. F. & Rock, D. L. (2002). The genome of swinepox virus. J Virol 76, 783-790.
4. Appleyard, G., Hapel, A. J. & Boulter, E. A. (1971). An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol 13, 9-17.
5. Boulter, E. A. & Appleyard, G. (1973). Differences between extracellular and intracellular forms of poxvirus and their implications. Prog Med Virol 16, 86-108.
6. Cameron, C., Hota-Mitchell, S., Chen, L., Barrett, J., Cao, J. X., Macaulay, C., Willer, D., Evans, D. & McFadden, G. (1999). The complete DNA sequence of myxoma virus. Virology 264, 298-318.
7. Chakrabarti, S., Sisler, J. R. & Moss, B. (1997). Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23, 1094-1097.
8. Davison, A. J. & Moss, B. (1989). Structure of vaccinia virus late promoters. J Mol Biol 210, 771-784.
9. Engelstad, M. & Smith, G. L. (1993). The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194, 627-637.
10. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
11. España, C. (1971). A pox disease of monkeys transmissible to man. In 2nd Conference of Experimental Medicine and Surgery in Primates, pp. 694-708. Basel: Karger.
12. Frischknecht, F., Moreau, V., Rottger, S., Gonfloni, S., Reckmann, I., Superti-Furga, G. & Way, M. (1999). Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401, 926-929.
13. Galmiche, M. C., Goenaga, J., Wittek, R. & Rindisbacher, L. (1999). Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology 254, 71-80.
14. Herrera, E., Lorenzo, M. M., Blasco, R. & Isaacs, S. N. (1998). Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J Virol 72, 294-302.
15. Hollinshead, M., Vanderplasschen, A., Smith, G. L. & Vaux, D. J. (1999). Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol 73, 1503-1517.
16. Hourcade, D., Holers, V. M. & Atkinson, J. P. (1989). The regulators of complement activation (RCA) gene cluster. Adv Immunol 45, 381-416.
17. Hu, Y., Lee, J., McCart, J. A., Xu, H., Moss, B., Alexander, H. R. & Bartlett, D. L. (2001). Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy. J Virol 75, 10300-10308.
18. Isaacs, S. N., Wolffe, E. J., Payne, L. G. & Moss, B. (1992). Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J Virol 66, 7217-7224.
19. Knight, J. C., Novembre, F. J., Brown, D. R., Goldsmith, C. S. & Esposito, J. J. (1989). Studies on Tanapox virus. Virology 172, 116-124.
20. Kotwal, G. J. & Moss, B. (1988). Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-178.
21. Law, M. & Smith, G. L. (2001). Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology 280, 132-142.
22. Law, M., Hollinshead, R. & Smith, G. L. (2002). Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol 83, 209-222.
23. Lee, H. J., Essani, K. & Smith, G. L. (2001). The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 281, 170-192.
24. Mackett, M., Smith, G. L. & Moss, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning. a Practical Approach, pp. 191-211. Edited by D. M. Glover. Oxford: IRL Press.
25. Martinez-Pomares, L., Stern, R. J. & Moyer, R. W. (1993). The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium. J Virol 67, 5450-5462.
26. Mathew, E., Sanderson, C. M., Hollinshead, M. & Smith, G. L. (1998). The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J Virol 72, 2429-2438.
27. Payne, L. G. (1978). Polypeptide composition of extracellular enveloped vaccinia virus. J Virol 27, 28-37.
28. 2+ influx into infected cells. J Virol 70, 905-914.
29. Sanderson, C. M., Frischknecht, F., Way, M., Hollinshead, M. & Smith, G. L. (1998). Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol 79, 1415-1425.
30. Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G. & Griffiths, G. (1994). Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans-Golgi network. J Virol 68, 130-147.
31. Senkevich, T. G., Bugert, J. J., Sisler, J. R., Koonin, E. V., Darai, G. & Moss, B. (1996). Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 273, 813-816.
32. Smith, G. L., Vanderplasschen, A. & Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83, 2915-2931.
33. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
34. Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Kutish, G. F. & Rock, D. L. (2001). Genome of lumpy skin disease virus. J Virol 75, 7122-7130.
35. Tulman, E. R., Afonso, C. L., Lu, Z. & 7 other authors (2002). The genomes of sheeppox and goatpox viruses. J Virol 76, 6054-6061.
36. van Eijl, H., Hollinshead, M. & Smith, G. L. (2000). The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 271, 26-36.
37. van Eijl, H., Hollinshead, M., Rodger, G., Zhang, W. H. & Smith, G. L. (2002). The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol 83, 195-207.
38. Willer, D. O., McFadden, G. & Evans, D. H. (1999). The complete genome sequence of shope (rabbit) fibroma virus. Virology 264, 319-343.
39. Wolffe, E. J., Weisberg, A. S. & Moss, B. (1998). Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology 244, 20-26.
40. Zhang, W. H., Wilcock, D. & Smith, G. L. (2000). Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol 74, 11654-11662.